S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,766.69 +1.36%
Next Bullish Trade
Sign in
PFE

Pfizer, Inc. PFE

$25.05 -0.09 (-0.36%)
Neutral · +0.70σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · PFE

Momentum reads · latest daily bar
Last
$25.05
-0.09 (-0.36%)
Mkt cap
$142.8B
Healthcare
RSI(14)
53.6
neutral
Stochastic %K
85.8
overbought
MFI(14)
61.4
neutral
ADX(14)
24.1
building

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $14.4B $2.7B $4.3B $2.2B 18.6% 29.5%
2025-12-31 $17.6B $-1.6B $3.7B $4.5B -9.4% 21.0%
2025-09-30 $16.7B $3.5B $5.5B $4.0B 21.3% 33.2%
2025-06-30 $14.7B $2.9B $3.8B $-1.2B 19.9% 25.7%
2025-03-31 $13.7B $3.0B $4.4B $1.8B 21.6% 32.3%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare PFE vs peers

Line PFE up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing PFE no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + TMO
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with PFE

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-05 0.75 0.72 +3.9% +0.3%
2026-02-03 0.66 0.57 +16.2% +3.9%
2025-11-04 0.87 0.63 +37.4% +1.3%
2025-08-05 0.78 0.57 +35.9% -3.3%
2025-04-29 0.92 0.67 +36.5% +2.6%
2025-02-04 0.63 0.46 +37.2% +2.2%
2024-10-29 1.06 0.61 +73.3% +0.2%
2024-07-30 0.60 0.46 +30.2% -2.7%
2024-05-01 0.82 0.51 +60.1% +1.9%
2024-01-30 0.10 -0.18 +154.7% +0.2%
2023-10-31 -0.17 -0.34 +50.0% -0.2%
2023-08-01 0.67 0.58 +15.3% -0.7%
2023-05-02 1.23 0.99 +24.7% -1.6%
2023-01-31 1.14 1.04 +9.4% -0.4%
2022-11-01 1.78 1.40 +27.0% -2.0%
2022-07-28 2.04 1.78 +14.8% -0.4%
2022-05-03 1.62 1.57 +3.5% +0.8%
2022-02-08 1.08 0.87 +23.6% -0.4%
2021-11-02 1.34 1.09 +23.5% -1.4%
2021-07-28 1.07 0.98 +9.4% -1.5%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE ★ $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%
ABT $175B 28.2 16.6 3.8 17.1 3.4 56.8% 13.0% -47.5% —

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 31.42%

HolderShares% out
Blackrock Inc. 498,257,550 8.74%
Vanguard Capital Management LLC 369,430,012 6.48%
State Street Corporation 301,589,865 5.29%
Geode Capital Management, LLC 133,561,742 2.34%
Vanguard Portfolio Management LLC 116,734,695 2.05%
Fisher Asset Management, LLC 104,964,427 1.84%
Morgan Stanley 92,685,370 1.63%
Northern Trust Corporation 62,026,552 1.09%
Massachusetts Financial Services Co. 56,911,830 1.00%
State Farm Mutual Automobile Insuran 54,508,560 0.96%

Insider activity · 90d

14 buys / 1 sells · ratio 14.0 · Finnhub

  • BOURLA ALBERT BUY 772,938 @ $24.25
  • BOURLA ALBERT BUY 772,979 @ $24.08
  • BOURLA ALBERT BUY 772,772 @ $26.00
  • DAMICO JENNIFER B. SELL 31,397 @ $25.70
  • BOURLA ALBERT BUY 772,789 @ $26.18
  • BOURLA ALBERT BUY 773,297 @ $25.33
  • BOURLA ALBERT BUY 760,229 @ $26.70
  • Buckley Mortimer J BUY 24,391 @ $26.67
  • LITTMAN DAN R. BUY 74,534 @ $26.67
  • Echevarria Joseph BUY 161,085 @ $26.67

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$24.0
Mean
$28.78692
High
$35.46
Analysts
26
Recommendation distribution · period 2026-07-01
6
9
19
1
1
Revision trend (2026-04-01 → 2026-07-01): net 12 → 13 +1 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-16 Insider transaction (Form 4) view ·
4 2026-07-13 Insider transaction (Form 4) view ·
4 2026-07-01 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
4 2026-06-30 Insider transaction (Form 4) view ·
8-K 2026-06-18 8-K view ·
8-K 2026-06-18 8-K view ·
4 2026-06-16 Insider transaction (Form 4) view ·
4 2026-06-10 Insider transaction (Form 4) view ·
4 2026-06-01 Insider transaction (Form 4) view ·
4 2026-05-18 Insider transaction (Form 4) view ·
13F-HR 2026-05-12 Institutional holdings (13F) view ·
10-Q 2026-05-05 10-Q view ·
8-K 2026-05-05 8-K view ·
4 2026-05-04 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
4 2026-04-27 Insider transaction (Form 4) view ·
8-K 2026-04-27 8-K view ·
4 2026-04-17 Insider transaction (Form 4) view ·
4 2026-04-16 Insider transaction (Form 4) view ·
4 2026-04-01 Insider transaction (Form 4) view ·
4 2026-03-30 Insider transaction (Form 4) view ·
4 2026-03-30 Insider transaction (Form 4) view ·
4 2026-03-30 Insider transaction (Form 4) view ·
4 2026-03-30 Insider transaction (Form 4) view ·
4 2026-03-30 Insider transaction (Form 4) view ·
4 2026-03-30 Insider transaction (Form 4) view ·
4 2026-03-16 Insider transaction (Form 4) view ·
DEF 14A 2026-03-12 DEF 14A view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-05 Insider transaction (Form 4) view ·
4 2026-03-03 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·

About PFE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well a…

Options picks · PFE

ITM + OTM ideas from the latest scan

Loading…

Congress trades · PFE

STOCK Act disclosures

Loading…

SEC filings & insiders · PFE

EDGAR · live

Loading…

Holders · PFE

Institutions & insider activity

Loading…